Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZX84
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injectors. The contract, valued at $5,678.70 with a firm fixed-price structure, is scheduled for completion by September 8, 2025. This delivery order was issued without set-aside designation, allowing the vendor to compete directly in the federal procurement market. DMS Pharmaceutical Group operates under a larger single-award Indefinite Delivery Contract with the DLA valued at $499.9 million and valid through November 2026, which enables the issuance of firm fixed-price delivery orders across a comprehensive pharmaceutical product portfolio.
As a critical supplier in the federal pharmaceutical supply chain since its registration in SAM.gov in 2001, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's established relationship with the Defense Logistics Agency encompasses a diverse range of pharmaceutical products, from oncology treatments to auto-injectors and specialty medications, supporting medical supply needs across Department of Defense healthcare sites globally. This delivery order for Nucala auto-injectors represents a continuation of the vendor's role in fulfilling the government's pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FZX84?
SPE2DB25FZX84 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FZX84 worth?
The government has obligated $5,679 on SPE2DB25FZX84.
Is contract SPE2DB25FZX84 an order under another contract?
Yes. SPE2DB25FZX84 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX84 competed?
The extent of competition for SPE2DB25FZX84 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award